Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (573)	4/27/2004 11:11:39 PM
From: Jibacoa	Respond to of 3722

IJX The medical devices holding company that makes the needle-free INJEX 30 System announced yesterday that its new board of directors has decided on a new course for IJX after acquiring Cathay Merchant Group Ltd. IJX will now focus on "merchant banking projects in China" and will change its name to "Cathay Merchant Group".<g> The company had an up-gap after the news yesterday and closed near its intra-day H. Today there was some profit taking, but the stock is still above its Jan 16- Jan 20 double top at the $0.71 level. Although IJX is no longer on a medical related field, the stock is interesting since it has no significant LTD, has around $0.70 in cash/share and the insiders hold around 15% of the shares. The float is around 13M. bigcharts.marketwatch.com It seems that the stock still has some room to run.<g> bigcharts.marketwatch.com Bernard